+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Dihydroartemisinin

BP0491
71939-50-9
98%
Biopurify
Dihydroartemisinin is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs, recommended as the first-line anti-malarial drug with low toxicity. Dihydroartemisinin has anticancer activity, it inhibited cell proliferation via AKT/GSK3β/cyclinD1/ERK pathway and induced apoptosis is associated with inhibition of Sarco/Endoplasmic reticulum Calcium ATPase activity in colorectal cancer.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0491-20mg 20mg
BP0491-100mg 100mg
BP0491-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

BCL2 STAT3 HIF1A TNF MMP9 NFKB1 IL6 VEGFA MTOR IL17A KDR
PFCRT PFMDR1 PFDHFR PFK13 PFATP6
BCL2 STAT3 TNF NFKB1 IL6 MTOR IL17A
NFKB1 IL6 ACE2

Dihydroartemisinin Related Products

Product drug property prediction parameters

  • 57.1500

  • 2.3129

  • 2.3128

  • .0565

  • 3.0840

  • 11.6419

  • High

  • 55.6363

  • 5.8044

  • Yes

  • No

  • No

  • No

  • Yes

  • No

  • 0.9

  • Yes

  • No

  • Yes

  • Yes

Dihydroartemisinin Reference LiteratureMORE+